John M. Leonard

2021 - Intellia Therapeutics

In 2021, John M. Leonard earned a total compensation of $9.8M as President, Chief Executive Officer at Intellia Therapeutics, a 169% increase compared to previous year.

Compensation breakdown

Bonus$462,000
Option Awards$6,876,888
Salary$600,000
Stock Awards$1,811,748
Other$22,924
Total$9,773,560

Leonard received $6.9M in option awards, accounting for 70% of the total pay in 2021.

Leonard also received $462K in bonus, $600K in salary, $1.8M in stock awards and $22.9K in other compensation.

Rankings

In 2021, John M. Leonard's compensation ranked 1,079th out of 12,415 executives tracked by ExecPay. In other words, Leonard earned more than 91.3% of executives.

ClassificationRankingPercentile
All
1,079
out of 12,415
91st
Division
Manufacturing
370
out of 5,505
93rd
Major group
Chemicals And Allied Products
131
out of 2,375
95th
Industry group
Drugs
110
out of 2,096
95th
Industry
In Vitro and In Vivo Diagnostic Substances
2
out of 61
97th
Source: SEC filing on May 2, 2022.

Leonard's colleagues

We found four more compensation records of executives who worked with John M. Leonard at Intellia Therapeutics in 2021.

2021

James Basta

Intellia Therapeutics

General Counsel

2021

Laura Sepp-Lorenzino

Intellia Therapeutics

Chief Scientific Officer

2021

David Lebwohl

Intellia Therapeutics

Chief Medical Officer

2021

Glenn Goddard

Intellia Therapeutics

Chief Financial Officer

News

In-depth

You may also like